Stocks / NASDAQ / Acer Therapeutics Inc.

Acer Therapeutics Inc.

Our Opinion

Acer Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“The medicines we are developing have some degree of established safety data from animal (pre-clinical) and human (clinical) studies undertaken previously. ” Read the full article.

Company Description

Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the treatment of vascular Ehlers-Danlos syndrome; and ACER-001 for the treatment of urea cycle disorders and maple syrup urine disease. The company was founded in 2013 and is headquartered in Newton, Massachusetts. [Source: Bloomberg]

Company Website: